Log in to save to my catalogue

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multic...

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1477565964

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

About this item

Full title

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

Publisher

England: Future Medicine Ltd

Journal title

Future oncology (London, England), 2014-01, Vol.10 (1), p.69-78

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

We investigated the role of erythropoietin (EPO) in reducing anemia and preventing the development of psychological distress in patients treated with chemotherapy.
This prospective observational study enrolled 591 adult patients receiving EPO at a dose of 30,000 IU administered once weekly for chemotherapy-induced anemia (mean baseline hemoglobi...

Alternative Titles

Full title

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1477565964

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1477565964

Other Identifiers

ISSN

1479-6694

E-ISSN

1744-8301

DOI

10.2217/fon.13.161

How to access this item